Living related donor liver transplantation for preoperative alpha-fetoprotein mRNA-positive patients of hepatocellular carcinoma: description of five cases.
Sato
Y
Y
Division of Digestive and General Surgery, Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Ichida
T
T
Suzuki
S
S
Yamamoto
S
S
Oya
H
H
Nakatsuka
H
H
Kobayashi
T
T
Watanabe
T
T
Kameyama
H
H
Hatakeyama
K
K
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001803:Blood Transfusion; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D004268:DNA-Binding Proteins; D005190:Family; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*; D016031:Liver Transplantation / Q000379:methods*; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011169:Portal Vein; D012333:RNA, Messenger / Q000235:genetics*; D012008:Recurrence; D019098:Telomerase / Q000235:genetics; D000509:alpha-Fetoproteins / Q000235:genetics*
D004268:DNA-Binding Proteins; D007166:Immunosuppressive Agents; D012333:RNA, Messenger; D000509:alpha-Fetoproteins; D019098:Telomerase